TY  - GEN
AU  - Visani,G
AU  - Bernasconi,P
AU  - Boni,M
AU  - Castoldi,G L
AU  - Ciolli,S
AU  - Clavio,M
AU  - Cox,M C
AU  - Cuneo,A
AU  - Del Poeta,G
AU  - Dini,D
AU  - Falzetti,D
AU  - Fanin,R
AU  - Gobbi,M
AU  - Isidori,A
AU  - Leoni,F
AU  - Liso,V
AU  - Malagola,M
AU  - Martinelli,G
AU  - Mecucci,C
AU  - Piccaluga,P P
AU  - Petti,M C
AU  - Rondelli,R
AU  - Russo,D
AU  - Sessarego,M
AU  - Specchia,G
AU  - Testoni,N
AU  - Torelli,G
AU  - Mandelli,F
AU  - Tura,S
TI  - The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients
SN  - 0887-6924
PY  - 2001///0712
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Chromosome Aberrations
KW  - Chromosome Deletion
KW  - Chromosome Inversion
KW  - Chromosomes, Human
KW  - ultrastructure
KW  - Combined Modality Therapy
KW  - Cytarabine
KW  - Daunorubicin
KW  - Disease-Free Survival
KW  - Etoposide
KW  - Female
KW  - Hematopoietic Stem Cell Transplantation
KW  - Hepatomegaly
KW  - epidemiology
KW  - Humans
KW  - Idarubicin
KW  - Karyotyping
KW  - Leukemia, Myeloid
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Mitoxantrone
KW  - Prognosis
KW  - Remission Induction
KW  - Retrospective Studies
KW  - Splenomegaly
KW  - Survival Analysis
KW  - Translocation, Genetic
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Review; Validation Study
UR  - https://doi.org/10.1038/sj.leu.2402142
ER  -